HSPB2 and breast cancer: Additionally, overexpression of HSP27 has been observed in acute myeloid leukemia, breast cancer, and oral squamous cell carcinoma [80,81,82], leading to the promotion of several aspects of carcinogenesis, including inhibition of apoptotic cell death and elevation of cytoprotection via direct interactions with several apoptotic proteins [83].